Treatment of Peritoneal Surface Malignancies State of the Art and Perspectives /

This monograph summarizes state of the art knowledge regarding peritoneal surface malignancies, with in-depth description of treatment options and the results achieved to date. It explores the most challenging problems on the basis of the authors’ very extensive clinical experience and examines the...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Συγγραφή απο Οργανισμό/Αρχή: SpringerLink (Online service)
Άλλοι συγγραφείς: Giorgio, Angelo Di (Επιμελητής έκδοσης), Pinto, Enrico (Επιμελητής έκδοσης)
Μορφή: Ηλεκτρονική πηγή Ηλ. βιβλίο
Γλώσσα:English
Έκδοση: Milano : Springer Milan : Imprint: Springer, 2015.
Σειρά:Updates in Surgery,
Θέματα:
Διαθέσιμο Online:Full Text via HEAL-Link
Πίνακας περιεχομένων:
  • Foreword
  • Preface 1
  • Preface 2
  • Introduction
  • Part 1 Background
  • 1 Peritoneal surface malignancies: definition
  • 2 Epidemiology: the extent of the problem
  • 3: Intraperitoneal spread: origin and mechanisms
  • 4 Pathology and patterns of molecular biology
  • 5 Classification of intraperitoneal spread
  • 6 Diagnosis and assessment: clinical, radiological, and laparoscopic
  • Part 2 Treatment
  • 7 Rationale for integrated procedures (combined cytoreduction and HIPEC)
  • 8 Peritonectomy techniques
  • 9 HIPEC techniques
  • 10 The role of surgery
  • 11 The role of systemic chemotherapy
  • 12 Anesthesiology and perioperative management
  • 13 Patient selection for treatment
  • 14 Morbidity and mortality
  • 15 Organizational problems, costs, and data collection
  • Part 3 Results of integrated treatment
  • 16 Pseudomyxoma peritonei
  • 17 Peritoneal mesothelioma
  • 18  Peritoneal carcinomatosis from gastric cancer
  • 19  Peritoneal carcinomatosis from colorectal cancer
  • 20  Peritoneal carcinomatosis from ovarian and gynecological cancers
  • 21 Other primary peritoneal surface malignancies
  • 22  Peritoneal carcinomatosis from other primary tumors
  • 23 Palliative treatments
  • Part 4 Perspectives
  • 24 New trials
  • 25 Main topics of discussion and new trends
  • Part 5 Conclusions.